Dr. Bota is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3151 Airway Ave
Ste R
Costa Mesa, CA 92626Phone+1 949-288-5377Fax+1 774-209-4466
Summary
- I am a board certified psychiatrist, specialized in treating treatment resistant depression, OCD and anxiety disorders
Education & Training
- HarvardTranscranial Magnetic Stimulation, 2017 - 2017
- University of Missouri-Kansas City School of MedicineResidency, Psychiatry, 2001 - 2005
- University of Southern CaliforniaMSG, Gerontology, 1999 - 2001
- Carol Davila University of Medicine and PharmacyClass of 1997
Certifications & Licensure
- AZ State Medical License 2024 - 2025
- CA State Medical License 2008 - 2025
- GA State Medical License 2004 - 2009
- NC State Medical License 2006 - 2007
- American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- Distinguished Fellow of American Psychiatric Association APA, 2016
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- Open Label Optimization Study Start of enrollment: 2023 Apr 06
Roles: Principal Investigator
Publications & Presentations
PubMed
- 1 citationsTranscranial magnetic stimulation-associated mania with psychosis: A case report.Erin D Knox, Robert G Bota
The Mental Health Clinician. 2021-11-01 - 3 citationsPersonalized TMS: role of RNA genotyping.Shawna Chan, Robert G. Bota
Mental Illness. 2019-11-04 - 2 citationsInteractions between antidepressants, sleep aids and selected breast cancer therapy.Jody Jacobson Wedret, Thanh G. Tu, Doru Paul, Camille Rousseau, Augustin Bonta
Mental Illness. 2019-03-22
Press Mentions
- World-Renowned Experts in Ketamine and TMS, Drs. David Mahjoubi and Robert Bota, Partner to Combine TMS and Ketamine for Enhanced NeuroplasticityJune 6th, 2024
- Magnus Medical Announces First Participants Treated in Study Using SAINT Neuromodulation System for Major DepressionJuly 26th, 2023
Professional Memberships
- Distinguished Fellow
- American Association for the Advancement of ScienceMember
- Clinical TMS SsocietyMember
External Links
- Instagram Accounthttps://www.instagram.com/brainhealthsolutions/
- Website Practicehttps://www.brainhealth-solutions.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: